MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Cytosorbents Corporation Operating Income 2011-2026 | CTSO
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Cytosorbents Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.7 M | -16.5 M | -31.9 M | -6.36 M | -9.56 M | -2.63 M | -19 M | -15.6 M | -9.84 M | -11.5 M | -9.3 M | -6.89 M | -4.71 M | -3.49 M | -4.44 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.63 M | -31.9 M | -11.1 M |
Quarterly Operating Income Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.86 M | -3.62 M | -3.89 M | - | -4.83 M | -3.57 M | -4.66 M | - | -7.35 M | -6.56 M | -7.89 M | - | -9.02 M | -8.36 M | -7.79 M | -9.56 M | -5.41 M | -4.92 M | -2.85 M | -2.63 M | -1.96 M | -3.3 M | -2.48 M | -5.43 M | -5.63 M | -3.63 M | -4.29 M | -5.59 M | -2.71 M | -4.19 M | -3.1 M | -3.81 M | -2.15 M | -2.33 M | -1.56 M | -4.57 M | -2.14 M | -2.69 M | -2.09 M | -2.21 M | -2.15 M | -2.23 M | -2.71 M | -2.89 M | -1.48 M | -1.36 M | -1.15 M | - | -880 K | -1.41 M | -1.42 M | - | -601 K | -1.01 M | -1.07 M | - | -1.23 M | -1.11 M | -1.13 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -601 K | -9.56 M | -3.5 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.0 | -0.58 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.15 | -2.51 % | $ 259 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 36.35 | -1.05 % | $ 5.42 K | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.71 | -1.44 % | $ 369 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
608 M | $ 168.12 | -2.18 % | $ 12.6 B | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 31.05 | -4.87 % | $ 1.43 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.01 | -2.91 % | $ 849 M | USA |
 |
TELA Bio
TELA
|
-33.8 M | $ 0.69 | 9.81 % | $ 32.4 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.65 | -0.52 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.58 | -0.11 % | $ 122 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 61.35 | -1.93 % | $ 90.8 B | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 11.1 | 1.19 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 34.34 | 0.81 % | $ 1.07 B | USA |
 |
Globus Medical
GMED
|
480 M | $ 90.53 | 2.15 % | $ 12.2 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 80.81 | -0.42 % | $ 47.3 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.76 | -7.37 % | $ 1.07 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 54.8 | 1.25 % | $ 1.61 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.0 | 0.34 % | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.37 | -0.29 % | $ 2.97 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.84 | -0.85 % | $ 69.8 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
5.96 B | $ 86.48 | 0.22 % | $ 111 B | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.67 | -4.29 % | $ 28 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |